ResidentThe Ohio State University Wexner Medical CenterDublin, Ohio, United States
Disclosure information not submitted.
SUN-653 - SGLT2 Inhibitor-Associated Euglycemic DKA Represents A Distinct Metabolic and Management Phenotype: A Real-World Cohort Study
Sunday, June 14, 20269:00 AM - 4:00 PM CT